4//SEC Filing
Tamayo Louis Edward 4
Accession 0001415889-25-023491
CIK 0001907108other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 2:00 PM ET
Size
7.6 KB
Accession
0001415889-25-023491
Insider Transaction Report
Form 4
Tamayo Louis Edward
Chief Financial Officer
Transactions
- Award
Common Stock
2025-08-29+45,000→ 45,000 total - Award
Stock Option (right to buy)
2025-08-29+280,000→ 280,000 totalExercise: $4.79Exp: 2035-08-28→ Common Stock (280,000 underlying)
Footnotes (3)
- [F1]The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on August 15, 2026, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]The reported securities are RSUs.
- [F3]25% of the shares underlying the option vest and become exercisable on August 15, 2026, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.
Documents
Issuer
Lexeo Therapeutics, Inc.
CIK 0001907108
Entity typeother
Related Parties
1- filerCIK 0002083206
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 2:00 PM ET
- Size
- 7.6 KB